Media Summary: insitro co-founder/CEO Daphne Koller, LinkedIn co-founder This is the first of a special, three-part April 23, 2024 For more information about Stanford's

Ai And Drug Discovery With Reid Hoffman - Detailed Analysis & Overview

insitro co-founder/CEO Daphne Koller, LinkedIn co-founder This is the first of a special, three-part April 23, 2024 For more information about Stanford's From Models to Medicines: Delivering on the Promise of This episode is our second installment of a special, three-part

Photo Gallery

AI and Drug Discovery with Reid Hoffman
How AI and data are transforming drug development and disease intervention
Global AI Summit: Unlocking Medical Discovery | Reid Hoffman & Siddhartha Mukherjee
The Power of AI: From Curing Cancer To Ballot Boxes
The first bank designed for AI customers
Reid Hoffman on AI | The Atlantic Festival 2025
I asked my AI twin to review my book
You're not using AI like THIS
Can AI outrun the FDA?
AI’s Next $1 Trillion Company Won’t Sell Software
Daphne Koller on drug discovery and AI
Stanford ECON295/CS323 I 2024 I Business of AI, Reid Hoffman
Sponsored
Sponsored
View Detailed Profile
AI and Drug Discovery with Reid Hoffman

AI and Drug Discovery with Reid Hoffman

Reid Hoffman

How AI and data are transforming drug development and disease intervention

How AI and data are transforming drug development and disease intervention

insitro co-founder/CEO Daphne Koller, LinkedIn co-founder

Sponsored
Global AI Summit: Unlocking Medical Discovery | Reid Hoffman & Siddhartha Mukherjee

Global AI Summit: Unlocking Medical Discovery | Reid Hoffman & Siddhartha Mukherjee

The cofounders of Manas

The Power of AI: From Curing Cancer To Ballot Boxes

The Power of AI: From Curing Cancer To Ballot Boxes

In this special episode of

The first bank designed for AI customers

The first bank designed for AI customers

In this episode of Possible,

Sponsored
Reid Hoffman on AI | The Atlantic Festival 2025

Reid Hoffman on AI | The Atlantic Festival 2025

Reid Hoffman

I asked my AI twin to review my book

I asked my AI twin to review my book

I sat down with my digital twin,

You're not using AI like THIS

You're not using AI like THIS

This is the first of a special, three-part

Can AI outrun the FDA?

Can AI outrun the FDA?

In this episode,

AI’s Next $1 Trillion Company Won’t Sell Software

AI’s Next $1 Trillion Company Won’t Sell Software

Reid

Daphne Koller on drug discovery and AI

Daphne Koller on drug discovery and AI

How can scientists leverage

Stanford ECON295/CS323 I 2024 I Business of AI, Reid Hoffman

Stanford ECON295/CS323 I 2024 I Business of AI, Reid Hoffman

April 23, 2024 For more information about Stanford's

Security In The AI Age

Security In The AI Age

Reid

Reid Hoffman on AI, Consciousness, and the Future of Labor

Reid Hoffman on AI, Consciousness, and the Future of Labor

Reid Hoffman

Yuval Noah Harari on the Dangers of AI

Yuval Noah Harari on the Dangers of AI

What will it take to create

How AI Could Transform Drug Development And The Life Sciences

How AI Could Transform Drug Development And The Life Sciences

The implementation of

Machine Learning in Drug Discovery Symposium: Keynote, Tom Miller

Machine Learning in Drug Discovery Symposium: Keynote, Tom Miller

From Models to Medicines: Delivering on the Promise of

You’re Thinking About AI All Wrong

You’re Thinking About AI All Wrong

This episode is our second installment of a special, three-part

Reid Hoffman On The Case For AI Optimism

Reid Hoffman On The Case For AI Optimism

This week on Prof G Markets,